BE870576A - Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant - Google Patents

Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant

Info

Publication number
BE870576A
BE870576A BE2057287A BE2057287A BE870576A BE 870576 A BE870576 A BE 870576A BE 2057287 A BE2057287 A BE 2057287A BE 2057287 A BE2057287 A BE 2057287A BE 870576 A BE870576 A BE 870576A
Authority
BE
Belgium
Prior art keywords
quinoleine
halogeno
dialkylamino
dihydro
oxo
Prior art date
Application number
BE2057287A
Other languages
English (en)
Inventor
M Pesson
Original Assignee
Bellon Labor Sa Roger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellon Labor Sa Roger filed Critical Bellon Labor Sa Roger
Publication of BE870576A publication Critical patent/BE870576A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2057287A 1977-09-20 1978-09-19 Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant BE870576A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39197/77A GB1598915A (en) 1977-09-20 1977-09-20 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them

Publications (1)

Publication Number Publication Date
BE870576A true BE870576A (fr) 1979-03-19

Family

ID=10408225

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2057287A BE870576A (fr) 1977-09-20 1978-09-19 Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant

Country Status (3)

Country Link
AU (1) AU520458B2 (fr)
BE (1) BE870576A (fr)
GB (1) GB1598915A (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006630A1 (fr) * 1985-05-14 1986-11-20 Beecham Group P.L.C. Utilisation de derives de quinolone pour le traitement de la pneumonie mycoplasmatique chez les porcs
EP0142426A3 (fr) * 1983-11-14 1986-12-17 Merck & Co. Inc. Formulation ophtalmique contenant de la norfloxacine et antibiotiques apparentés
EP0210513A1 (fr) * 1985-07-24 1987-02-04 Bayer Ag Préparations pour le traîtement des mycoplasmoses et des infections bactériennes chez la volaille
FR2655545A1 (fr) * 1989-12-11 1991-06-14 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US9012474B2 (en) 2006-02-17 2015-04-21 Idexx Laboratories Inc. Fluoroquinolone compositions

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
SE9904108D0 (sv) 1999-11-15 1999-11-15 New Pharma Research Ab Nya föreningar
ES2581056T3 (es) 2011-11-08 2016-08-31 Actelion Pharmaceuticals Ltd. Derivados de 2-oxo-oxazolidin-3,5-diilo antibióticos

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142426A3 (fr) * 1983-11-14 1986-12-17 Merck & Co. Inc. Formulation ophtalmique contenant de la norfloxacine et antibiotiques apparentés
WO1986006630A1 (fr) * 1985-05-14 1986-11-20 Beecham Group P.L.C. Utilisation de derives de quinolone pour le traitement de la pneumonie mycoplasmatique chez les porcs
EP0210513A1 (fr) * 1985-07-24 1987-02-04 Bayer Ag Préparations pour le traîtement des mycoplasmoses et des infections bactériennes chez la volaille
US5145853A (en) * 1985-07-24 1992-09-08 Bayer Aktiengesellschaft Bactericidal formulations for use in veterinary medicine
FR2655545A1 (fr) * 1989-12-11 1991-06-14 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
EP0437128A2 (fr) 1989-12-11 1991-07-17 Rhone-Poulenc Sante Utilisation des dérivés des fluoroquinolones pour le traitement de la pneumonie à Pneumocystis carinii
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US9012474B2 (en) 2006-02-17 2015-04-21 Idexx Laboratories Inc. Fluoroquinolone compositions

Also Published As

Publication number Publication date
GB1598915A (en) 1981-09-23
AU520458B2 (en) 1982-02-04
AU3996278A (en) 1980-03-27

Similar Documents

Publication Publication Date Title
BE877596A (fr) Nouvelles oxybenzylidene bornanones, procede pour leur preparation et compositions cosmetiques les contenant
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
BE885269A (fr) Nouveaux tensio-actifs non ioniques, leur procede de preparation et composition les contenant
BE868173A (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant
FR2449693B1 (fr) Complexes oxyde-carboxylate de magnesium, procede pour leur preparation et compositions les contenant
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
BE885268A (fr) Nouveaux n-propionyl-sarcosine-anilides, procede pour leur preparation et medicaments les contenant
BE870576A (fr) Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
BE864862A (fr) Nouveaux benzylidene camphres, leur procede de preparation et compositions cosmetiques les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
FR2333496A2 (fr) Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant
FR2562071B1 (fr) Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
BE867249A (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
BE884083A (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2526798B1 (fr) Derives de peneme, leur procede de preparation et compositions therapeutiques les contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2526425B1 (fr) Derives de cycloalcanes, procede pour leur preparation et compositions les contenant
BE844672A (fr) Nouveaux immonologiques, procede pour leur obtention et compositions les contenant

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0092

CCPV Grant of a supplementary protection certificate

Free format text: 093C0092, EXPIRES 19990807

RE20 Patent expired

Owner name: LABORATOIRE ROGER BELLON

Effective date: 19980919

CCRE Expiry of a supplementary protection certificate

Free format text: 093C0092